Amgen Inc (XTER:AMG)
€ 265.4 15.2 (6.08%) Market Cap: 143.51 Bil Enterprise Value: 192.49 Bil PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 88/100

Q4 2018 Amgen Inc Earnings Call Transcript

Jan 29, 2019 / 10:00PM GMT
Release Date Price: €167.93 (+0.77%)
Operator

My name is Ian, and I'll be your conference facilitator today for Amgen's Fourth Quarter 2018 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay, thank you, Ian. Good afternoon, everybody. Thanks for joining us today. Let's go ahead and jump right in as we have a lot of ground to cover.

I think 2018 is a good illustration of how the capabilities we have developed over the past 5 years will help drive long-term growth for our shareholders. To describe this in much greater detail, I'm joined today by our Chairman and CEO, Bob Bradway. After Bob's strategic overview, our CFO, David Meline, will review our financial results for the fourth quarter and the full year 2018 and provide guidance for 2019. Our Head of Global Commercial Operations, Murdo Gordon, will then review our product performance; following which, Dave Reese, our Head of R&D, will provide a pipeline update. We will use

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot